These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 26572563)

  • 1. Avoiding bias and incorrect confidence interval coverage in prescription drug labeling.
    Levin G
    Clin Trials; 2016 Apr; 13(2):199-204. PubMed ID: 26572563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point and interval estimation of primary and secondary parameters in a two-stage adaptive clinical trial.
    Liu A; Wu C; Yu KF
    J Biopharm Stat; 2008; 18(2):211-26. PubMed ID: 18327717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation issues in clinical trials and overviews.
    Pocock SJ; Hughes MD
    Stat Med; 1990 Jun; 9(6):657-71. PubMed ID: 2145623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical Bayes interval estimates that are conditionally equal to unadjusted confidence intervals or to default prior credibility intervals.
    Bickel DR
    Stat Appl Genet Mol Biol; 2012 Feb; 11(3):Article 7. PubMed ID: 22499708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.
    Willke RJ; Burke LB; Erickson P
    Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
    Cheng Y; Shen Y
    Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonparametric confidence intervals for Tmax in sequence-stratified crossover studies.
    Willavize SA; Morgenthien EA
    Pharm Stat; 2008; 7(1):9-19. PubMed ID: 17256803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary care physicians' use of FDA-approved prescription drug labels.
    Sullivan HW; O'Donoghue AC; Aikin KJ
    J Am Board Fam Med; 2014; 27(5):694-8. PubMed ID: 25201939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculating confidence intervals for prediction error in microarray classification using resampling.
    Jiang W; Varma S; Simon R
    Stat Appl Genet Mol Biol; 2008; 7(1):Article8. PubMed ID: 18312213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two bias-corrected covariance estimators for generalized estimating equations.
    Lu B; Preisser JS; Qaqish BF; Suchindran C; Bangdiwala SI; Wolfson M
    Biometrics; 2007 Sep; 63(3):935-41. PubMed ID: 17825023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of confidence interval methods for the intraclass correlation coefficient in community-based cluster randomization trials with a binary outcome.
    Braschel MC; Svec I; Darlington GA; Donner A
    Clin Trials; 2016 Apr; 13(2):180-7. PubMed ID: 26415500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional and unconditional confidence intervals following a group sequential test.
    Fan X; DeMets DL
    J Biopharm Stat; 2006; 16(1):107-22. PubMed ID: 16440840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the calculation of confidence intervals for the number needed to treat.
    Bender R
    Stud Health Technol Inform; 2000; 77():29-32. PubMed ID: 11187559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical methods for the meta-analysis of diagnostic tests must take into account the use of surrogate standards.
    Kang J; Brant R; Ghali WA
    J Clin Epidemiol; 2013 May; 66(5):566-574.e1. PubMed ID: 23466018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative methods to evaluate trial level surrogacy.
    Abrahantes JC; Shkedy Z; Molenberghs G
    Clin Trials; 2008; 5(3):194-208. PubMed ID: 18559408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Information comparison of the effects of drugs on laboratory tests in drug labels and Young's book.
    Geerts AF; De Koning FH; Egberts TC; De Smet PA; Van Solinge WW
    Clin Chem Lab Med; 2012 Oct; 50(10):1765-8. PubMed ID: 23089706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of clinical trials with early stopping: an investigation of potential bias.
    Schou IM; Marschner IC
    Stat Med; 2013 Dec; 32(28):4859-74. PubMed ID: 23824994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stopping a trial early - and then what?
    Wittes J
    Clin Trials; 2012 Dec; 9(6):714-20. PubMed ID: 22879573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bias of estimates of the number needed to treat.
    Duncan BW; Olkin I
    Stat Med; 2005 Jun; 24(12):1837-48. PubMed ID: 15806616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.